Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 123

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 123
---
,513 |     |   10,412 |     |      12,925 |     |         — |     | —            |

Notes to the table:

| 1. | The closing market price of the Company’s ordinary shares as at 31 December 2024 was $29.50 (2023: $68.32). |

| 2. | 2024: No share options were exercised. Bahija Jallal exercised 225,000 share options during 2023, resulting in a gain of $9,724,878. |

| 3. | No performance conditions apply to any share options. |

The information provided in this part of the Directors’ Remuneration Report is not subject to audit: TSR Performance Graph The graph below shows a comparison, from 5 February 2021 (the date our ADSs commenced trading on Nasdaq) through 31 December 2024, of the cumulative total return to shareholders of our ADSs relative to the Nasdaq Composite Index and the Nasdaq Biotech Index. The graph assumes that $100 was invested in each of our ADSs, the Nasdaq Composite Index and the Nasdaq Biotech Index at their respective closing prices on 5 February 2021 and assumes reinvestment of gross dividends. The share price performance shown in the graph represents past performance and should not be considered an indication of future share price performance

A-23

TABLE OF CONTENTS

Aligning Pay with Performance 2021 was the first year that the Company has prepared a Remuneration Report and as the Company was incorporated on 7 January 2021, and we do not have any historical remuneration to disclose for periods prior to 2021.

|                     |     |        Total 
 remuneration 
            $ |     | Annual bonus   
 (percentage of 
 target)        |     | Share options vested 
   during the year(1) |
| 2024                |     |              |     |                |     |                      |
| Executive Director  |     |    1,474,165 |     | 100%           |     |              877,329 |
| Bahija Jallal       |     |              |     |                |     |                      |
| 2023                |     |              |     |                |     |                      |
| Executive Director: |     |    1,403,204 |     | 110%           |     |            1,240,914 |
|